HAVCR2 and neoplasm: As described earlier, binding of TIM-3 on dendritic cells to HMGB1 leads to impaired endocytosis of PAMPs and nucleic acids from apoptotic tumor cells, which suppresses antigen presentation and the innate immune response (188).